The Use of Tranexamic Acid for Upper Gastrointestinal Bleeding by Medical and Surgical Intensivists: A Single Center Experience
- PMID: 28912909
- PMCID: PMC5593442
- DOI: 10.14740/gr891w
The Use of Tranexamic Acid for Upper Gastrointestinal Bleeding by Medical and Surgical Intensivists: A Single Center Experience
Abstract
Background: Tranexamic acid (TXA) may be beneficial in the management of upper gastrointestinal bleeding (UGIB). We sought to investigate how frequently intensivists at our academic institution use TXA for patients with UGIB, and to investigate whether the utilization rate of TXA differs between surgical and medical intensivists, and provide an updated literature review on the subject.
Methods: We performed a retrospective cohort study of patients admitted for UGIB to the surgical intensive care unit (SICU) and the medical intensive care unit (MICU) at our academic healthcare facility (University of Florida Health - Shands Hospital) from January 1, 2013 to December 31, 2016. The patients were categorized as receiving or not receiving TXA. The overall utilization rate of TXA was calculated, and the utilization rates for the MICU and SICU were compared using a two-sample test for equality of two proportions with continuity correction.
Results: The study cohort included a total of 1,829 patients with a diagnosis of UGIB. Of those, 988 were treated in the MICU and 841 were treated in the SICU. Of the 988 patients in the MICU, six received TXA (0.61%), while 10 (1.19%) of the 841 patients in the SICU received TXA. The overall utilization rate of TXA was 0.87%. The odds of receiving TXA in the SICU were 1.97 times greater than in the MICU (odds ratio (OR): 1.97, 95% confidence interval (CI): 0.74 - 5.2, P = 1.83).
Conclusions: Our study suggests that TXA may be underused in the management of UGIB, and that the utilization rate does not differ significantly between surgical and medical intensivists.
Keywords: Intensivists; Tranexamic acid; Upper gastrointestinal bleeding.
Similar articles
-
Efficacy and tolerance of early administration of tranexamic acid in patients with cirrhosis presenting with acute upper gastrointestinal bleeding: a study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (the EXARHOSE study).BMJ Open. 2018 Aug 10;8(8):e021943. doi: 10.1136/bmjopen-2018-021943. BMJ Open. 2018. PMID: 30099397 Free PMC article.
-
Indications and complications of arterial catheter use in surgical or medical intensive care units: analysis of 4932 patients.Am Surg. 1998 Feb;64(2):127-31. Am Surg. 1998. PMID: 9486883
-
The Trend of Tranexamic Use in Upper Gastrointestinal Bleeding Ulcers.Gastroenterology Res. 2017 Jun;10(3):159-165. doi: 10.14740/gr836w. Epub 2017 Jun 30. Gastroenterology Res. 2017. PMID: 28725302 Free PMC article.
-
Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid: A systematic review and meta-analysis.Thromb Res. 2019 Jul;179:81-86. doi: 10.1016/j.thromres.2019.05.003. Epub 2019 May 5. Thromb Res. 2019. PMID: 31100632
-
A comparison of combined intravenous and topical administration of tranexamic acid with intravenous tranexamic acid alone for blood loss reduction after total hip arthroplasty: A meta-analysis.Int J Surg. 2017 May;41:34-43. doi: 10.1016/j.ijsu.2017.03.031. Epub 2017 Mar 21. Int J Surg. 2017. PMID: 28336258 Review.
Cited by
-
Tranexamic acid as treatment for acute gastrointestinal bleeding: A comprehensive systematic review and meta-analysis.Indian J Gastroenterol. 2025 Jun;44(3):311-329. doi: 10.1007/s12664-025-01749-9. Epub 2025 Mar 3. Indian J Gastroenterol. 2025. PMID: 40029534
-
Defining Intensivists: A Retrospective Analysis of the Published Studies in the United States, 2010-2020.Crit Care Med. 2024 Feb 1;52(2):223-236. doi: 10.1097/CCM.0000000000005984. Epub 2024 Jan 19. Crit Care Med. 2024. PMID: 38240506 Free PMC article.
References
-
- Williams-Johnson JA, McDonald AH, Strachan GG, Williams EW. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) A randomised, placebo-controlled trial. West Indian Med J. 2010;59(6):612–624. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources